MARSH & MCLENNAN COMPANIES, INC.
No enriched coverage for $MRSH in the last 7 days.
Marsh & McLennan CEO John Q. Doyle sold 16,656 shares at $188.51 each on Sept. 2, 2026, using a 10b5-1 plan. Post-sale, he holds ~117,000 shares. The stock has a -9% one-year return. The company has a $90.4B market cap, $27.9B TTM revenue, and $4.0B net income.
Marsh & McLennan (MRSH) faces declining insurance pricing but is investing in AI to drive growth. Q2 saw 5% revenue growth, 9% adjusted EPS growth, and a 29.3% adjusted operating margin. Peers Aon (AON) and Willis Towers Watson (WTW) also reported Q2 growth and margin improvements. MRSH shares are down 4.7% YTD, outperforming the industry.
Ryan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.
Recent MRSH coverage spans financial news, insider activity and technology.
In the last 30 days, MRSH insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($3.4M). The most active reporter was Brennan Katherine, SVP and General Counsel, with 1 filing. 50% of those filings were made under pre-arranged Rule 10b5-1 plans.
The insider sale represents a modest reduction of the CEO's stake, but no immediate price impact is indicated.
AI initiatives may offset pricing pressure but short‑term impact on stock is limited.
Earnings beat but modest revenue growth limits upside.
The new ticker consolidates multiple insurance brands, likely improving brand clarity and could affect liquidity and valuation multiples.
Insider sale by the CEO may signal reduced confidence, potentially pressuring the stock lower.
AlphAI scores every news story that mentions MRSH with an AI model for sentiment and relevance, and aggregates insider trades from MARSH & MCLENNAN COMPANIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Marsh & McLennan CEO John Q. Doyle sold 16,656 shares at $188.51 each on Sept. 2, 2026, using a 10b5-1 plan. Post-sale, he holds ~117,000 shares. The stock has a -9% one-year return. The company has a $90.4B market cap, $27.9B TTM revenue, and $4.0B net income.
2 min readMarsh & McLennan (MRSH) faces declining insurance pricing but is investing in AI to drive growth. Q2 saw 5% revenue growth, 9% adjusted EPS growth, and a 29.3% adjusted operating margin. Peers Aon (AON) and Willis Towers Watson (WTW) also reported Q2 growth and margin improvements. MRSH shares are down 4.7% YTD, outperforming the industry.
2 min readRyan Specialty beat estimates but fell 11.1% to $39.20. Brown & Brown (BRO) reported $1.68B revenue, up 30.4% YoY, missing estimates by 2.5%, and dropped 3.4% to $67.32. Arthur J. Gallagher (AJG) reported $4.00B revenue, up 24.3% YoY, missing estimates by 0.5%, and fell 3.3% to $248.05. Marsh (MRSH) reported $7.40B revenue, up 6.2% YoY, beating estimates by 1.8%, and dropped 1.2% to $179.91.
2 min readMarsh McLennan is rebranding its reinsurance broking arm, Guy Carpenter, to Marsh Re as part of a broader simplification of its corporate structure. The change, announced in 2025 and implemented in 2026, aligns with the company's strategy to unify its brands. Guy Carpenter, founded in 1922, is a significant player in the reinsurance industry, placing $75 billion in ceded premium in 2025. The rebranding is part of a broader industry trend towards unified branding.
2 min readDoyle John Q (President and CEO) sold 16,656 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $188.51 ($3.14M total) on 2026-09-02 under a Rule 10b5-1 trading plan.
1 min readBrennan Katherine (SVP and General Counsel) sold 1,197 shares of MARSH & MCLENNAN COMPANIES, INC. (MRSH) at $187.90 ($0.22M total) on 2026-09-02.
1 min readMarsh & McLennan (MRSH) reported moderate 2027 pay hikes, with average merit raises at 3.2% and total salary increases at 3.5%. High Tech and Banking sectors lead in merit budgets, while AI adoption in compensation planning remains basic. Marsh and Resilience launched Cyber Protect in Asia, addressing low cyber risk confidence. MRSH shares gained 2.3% YTD, outperforming the industry.
2 min readMarsh & McLennan (MRSH) reported Q2 2026 earnings with revenue up 6.2% YoY to $7.4B and adjusted EPS up 8.8% to $2.96, beating estimates. Shares fell 3.1% post-earnings due to segment weakness. Analysts expect 7% YoY EPS growth for FY2026, with a consensus 'Moderate Buy' rating and mean price target of $202.54.
5 min readGoldman Sachs says investors have focused on AI infrastructure more than AI productivity beneficiaries. It reports Q2 S&P 500 EPS growth of 31% YoY, with infrastructure about half. Only 11% of S&P 500 firms quantified AI productivity impacts. Goldman estimates AI inference is <0.5% of S&P 500 revenues and has screened 20 stocks, including EBAY and CS GP.
6 min readMarsh McLennan Agency (MMA) will acquire Accel Group, a privately held Iowa-based insurance broker founded in 1936, with seven offices and 130+ employees. Accel’s services include commercial and personal insurance, employee benefits, agribusiness coverage, and wealth and retirement advisory. MMA said the deal expands rural and agribusiness capacity, following similar regional acquisitions.
4 min read
